Recent News

• 09.17.2025 - CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference
• 09.17.2025 - CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - CervoMed to Participate in Upcoming Investor Conferences
• 09.03.2025 - CervoMed to Participate in Upcoming Investor Conferences
• 08.12.2025 - Canaccord Genuity 45th Annual Growth Conference
• 08.12.2025 - Canaccord Genuity 45th Annual Growth Conference
• 08.11.2025 - CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
• 08.11.2025 - CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Recent Filings

• 08.20.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 8-K Current report
• 08.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - 8-K Current report